Pegasys (Genentech, Inc.)
Welcome to the PulseAid listing for the Pegasys drug offered from Genentech, Inc.. This Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | peginterferon alfa-2a |
SUBSTANCE NAME: | PEGINTERFERON ALFA-2A |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2002-10-16 |
END MARKETING DATE: | 0000-00-00 |
Pegasys HUMAN PRESCRIPTION DRUG Details:
Item Description | Pegasys from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 180(ug/mL) |
START MARKETING DATE: | 2002-10-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0004-0350_1b19b557-1e64-485f-8200-9b98ad757e6b |
PRODUCT NDC: | 0004-0350 |
APPLICATION NUMBER: | BLA103964 |
Other PEGINTERFERON ALFA-2A Pharmaceutical Manufacturers / Labelers: